Biopsies are an integral part of determining a patient’s condition. And just like any other medical treatment, there are risks that can cause patient apprehension, such as internal bleeding. This is where SinglePass Inc.’s mission is rooted: reducing the risk of internal bleeding and giving patients a safer, more effective procedure.
SinglePass Inc.’s primary focus is specializing in products for interventional radiologists, patients, and companies. However, their flagship offering is a single-use disposable device engineered to enhance biopsy procedures significantly. This technology aims to improve patient care by easing their anxiety about internal bleeding and lessening their hospital stay to monitor possible adverse events, among others.
This elevated methodology of biopsy procedure also helps the medical staff with its user-friendly, lightweight design. Being the first of its kind currently in the industry, this innovation has not only garnered considerable interest but has also resulted in two issued patents and two additional patents pending, underscoring the company’s dedication to continuous innovation and excellence.
CEO Bill Colone fervently expresses the company’s driving force: “Our satisfaction stems from the realization that our technology is affecting a comprehensive transformation in the medical community and inpatient treatment. We are not only contributing to saving healthcare costs but also reducing financial burdens for insurance providers and conserving invaluable nursing time. Additionally, we are elevating the peace of mind of patients and their families, delivering heightened value to medical staff in the process.”
Bill Colone has 40 years of experience in medical device development and 13 U.S. patents under his belt, along with his team of experienced medical professionals. The company’s principles, such as respect, consistency, and delivering results, are the reliability and effectiveness of their product. Respect is fundamental in treating the team, partners, and customers. At the same time, consistency and delivering results are central to their commitment to making a meaningful impact in the healthcare space.
In a market demanding novel solutions, SinglePass Inc. presents an unparalleled product addressing a critical need in the healthcare sector. The team is poised to become a trusted expert in the field, thanks to their unique device that enhances biopsy procedures and their deep understanding of the challenges faced by interventional radiologists.
